Renal cell carcinoma, often abbreviated as RCC, is the most common type of kidney cancer in adults. It develops from the cells that line the small tubules inside the kidney and can vary from a small localized tumor to a more advanced disease that has spread beyond the kidney.
Early diagnosis plays a major role in improving treatment outcomes. Many kidney tumors are discovered incidentally during an ultrasound or CT scan performed for another medical reason, often before symptoms become severe.
Modern renal cell carcinoma treatment has advanced significantly and may include surgery, targeted therapy, immunotherapy, surveillance and specialized long-term kidney care depending on the stage of the disease and the patient’s overall health.
At Prabhakar Bhurke Clinic, Dr. Sandip Prabhakar Bhurke, super specialist nephrologist and transplant physician, provides comprehensive kidney evaluation, kidney function management and coordinated care for patients with kidney tumors and kidney cancer related conditions.
What is renal cell carcinoma?
Renal cell carcinoma is a malignant tumor that arises from the kidney tissue itself.
The major subtypes include:
-
Clear cell renal cell carcinoma
-
Papillary renal cell carcinoma
-
Chromophobe renal cell carcinoma
-
Other less common subtypes
Treatment depends on the tumor size, stage, location and the patient’s kidney function.
Common symptoms of renal cell carcinoma
Early kidney cancer may cause no symptoms.
When symptoms occur, they may include:
-
Blood in the urine
-
Flank pain
-
A lump in the side or abdomen
-
Unexplained weight loss
-
Fatigue
-
Fever
-
Loss of appetite
-
Anemia
-
High blood pressure in some cases
Blood in the urine is one of the most important warning signs and should always be medically evaluated.
What causes renal cell carcinoma?
The exact cause is not always known, but several risk factors are associated with RCC.
Smoking
Smoking significantly increases the risk of kidney cancer.
Obesity
Excess body weight is associated with a higher risk of RCC.
High blood pressure
Hypertension has been linked with an increased risk of kidney cancer.
Chronic kidney disease
Certain kidney disorders may increase kidney cancer risk.
Family history
Some inherited genetic syndromes are associated with RCC.
Long term dialysis
Some patients with advanced kidney disease requiring long-term dialysis have an increased risk of certain kidney tumors.
How is renal cell carcinoma diagnosed?
Diagnosis usually involves imaging and laboratory evaluation.
Ultrasound
Ultrasound may identify a kidney mass that requires further evaluation.
CT scan
CT imaging is one of the most important tests for evaluating:
-
Tumor size
-
Tumor location
-
Local spread
-
Lymph node involvement
-
Blood vessel involvement
-
Distant spread
MRI
MRI may be used when additional anatomical information is needed.
Blood tests
These may assess:
-
Kidney function
-
Hemoglobin
-
Electrolytes
-
Liver function
-
Other general health parameters
Urine tests
Urine examination may detect blood and other abnormalities.
Staging of renal cell carcinoma
Treatment planning depends heavily on the stage of the cancer.
In general:
-
Localized RCC: confined to the kidney
-
Locally advanced RCC: extends into nearby structures or blood vessels
-
Metastatic RCC: has spread to distant organs
Accurate staging is essential before treatment decisions are made.
Renal cell carcinoma treatment options
Treatment is individualized according to the stage of disease, kidney function, age, overall health and patient preferences.
Partial nephrectomy
When feasible, partial nephrectomy removes the tumor while preserving the remaining healthy kidney tissue.
This approach is often considered for:
-
Small kidney tumors
-
Solitary kidneys
-
Reduced kidney function
-
Bilateral kidney tumors in selected cases
Kidney preservation can be important for long-term kidney function.
Radical nephrectomy
Radical nephrectomy involves removal of the entire affected kidney and surrounding structures when necessary.
This may be recommended for:
-
Large tumors
-
Centrally located tumors
-
Tumors not suitable for partial nephrectomy
-
Certain advanced localized cancers
Minimally invasive surgery
Many kidney surgeries can be performed using laparoscopic or robotic techniques in appropriate patients.
Potential advantages may include:
-
Smaller incisions
-
Less pain
-
Shorter hospital stay
-
Faster recovery
Suitability depends on the tumor and the patient’s condition.
Active surveillance
Not every small kidney tumor requires immediate surgery.
In selected patients, especially those with:
-
Very small tumors
-
Significant medical comorbidities
-
Advanced age
-
Limited life expectancy
careful monitoring with periodic imaging may be considered.
Ablative therapies
Selected small tumors may be treated with image-guided techniques such as:
-
Cryoablation
-
Radiofrequency ablation
These treatments are not appropriate for every patient and require careful selection.
Targeted therapy
For advanced or metastatic renal cell carcinoma, targeted medications may be used.
These drugs act on specific pathways involved in tumor growth and blood vessel formation.
Treatment selection depends on the cancer subtype and stage.
Immunotherapy
Immunotherapy has become an important treatment option for many patients with advanced RCC.
These medicines help the immune system recognize and attack cancer cells.
Immunotherapy may be used alone or in combination with targeted therapy depending on the clinical situation.
Can renal cell carcinoma be cured?
Localized kidney cancer can often be treated successfully, particularly when diagnosed early.
The likelihood of cure depends on:
-
Tumor stage
-
Tumor size
-
Histological subtype
-
Surgical completeness
-
Overall health
Advanced disease may require long-term systemic treatment and monitoring.
Recovery after kidney cancer surgery
Recovery varies according to the procedure performed.
Factors influencing recovery include:
-
Partial versus radical nephrectomy
-
Surgical approach
-
Kidney function
-
Age
-
Other medical conditions
Regular follow-up is important after treatment.
Life with one kidney
Many people live normal lives with one healthy kidney.
After nephrectomy, monitoring may include:
-
Kidney function tests
-
Blood pressure monitoring
-
Urine testing
-
Imaging follow-up
-
Lifestyle and dietary guidance
Protecting the remaining kidney becomes especially important.
Follow up after renal cell carcinoma treatment
Regular surveillance is essential.
Follow-up may include:
-
CT scans
-
Ultrasound
-
Chest imaging
-
Kidney function tests
-
Blood pressure assessment
-
Clinical examination
The frequency depends on the stage of the cancer and the treatment received.
Can kidney cancer return after treatment?
Yes.
Recurrence can occur locally or in distant organs.
Long-term follow-up is therefore an important part of kidney cancer care.
Protecting kidney function after treatment
Patients should:
-
Control blood pressure
-
Manage diabetes
-
Avoid smoking
-
Stay adequately hydrated when appropriate
-
Avoid unnecessary kidney harming medications
-
Attend regular nephrology follow-up
-
Monitor kidney function periodically
When should you seek medical evaluation?
Seek medical attention if you experience:
-
Blood in the urine
-
Persistent flank pain
-
Unexplained weight loss
-
A palpable abdominal lump
-
Persistent fatigue
-
Fever without an obvious cause
-
Worsening kidney function
Early evaluation can improve treatment options.
Kidney cancer care at Prabhakar Bhurke Clinic
At Prabhakar Bhurke Clinic, Dr. Sandip Prabhakar Bhurke provides specialized kidney-focused care for patients with renal tumors and kidney cancer related conditions.
Services may include:
-
Kidney function assessment
-
Imaging review
-
Preoperative kidney evaluation
-
Post nephrectomy kidney monitoring
-
Chronic kidney disease management
-
Blood pressure management
-
Long-term kidney protection
-
Coordination of multidisciplinary kidney cancer care
Treatment planning focuses on both cancer control and preservation of kidney function whenever possible.
Frequently Asked Questions
What is the best treatment for renal cell carcinoma?
The best treatment depends on the stage, size and location of the tumor and the patient’s kidney function. Surgery is often the primary treatment for localized RCC.
Can kidney cancer be treated without removing the kidney?
In selected patients, partial nephrectomy, surveillance or ablative therapies may be appropriate.
Is renal cell carcinoma curable?
Early-stage localized renal cell carcinoma can often be treated successfully with surgery.
Will I need dialysis after kidney removal?
Most patients with a healthy remaining kidney do not require dialysis after removal of one kidney, but kidney function should be monitored regularly.
How often is follow-up needed after RCC treatment?
Follow-up schedules vary according to the stage of cancer and treatment received. Your treating team will recommend an individualized surveillance plan.
Conclusion
Renal cell carcinoma treatment has evolved significantly, and many patients benefit from early diagnosis, kidney preserving surgery and modern systemic therapies. The most appropriate treatment depends on the stage of the cancer, kidney function and overall health.
Regular follow-up and kidney function monitoring remain important after treatment to protect long-term kidney health.
For comprehensive kidney evaluation and coordinated renal cell carcinoma related kidney care, patients can consult Dr. Sandip Prabhakar Bhurke at Prabhakar Bhurke Clinic.
Medical Disclaimer
This article is intended for general educational purposes only and does not constitute medical advice, diagnosis or treatment. Renal cell carcinoma requires individualized evaluation, imaging, staging and treatment planning by qualified specialists. Treatment options including surgery, surveillance, targeted therapy and immunotherapy depend on the tumor stage, subtype, kidney function and overall health. Do not ignore blood in the urine, persistent flank pain, unexplained weight loss or other concerning symptoms. For personalized diagnosis and treatment, consult Dr. Sandip Prabhakar Bhurke or another qualified nephrologist and oncology specialist.


